>
Switch to:

Johnson & Johnson Price-to-Free-Cash-Flow

: 19.38 (As of Today)
View and export this data going back to 1944. Start your Free Trial

As of today (2021-10-23), Johnson & Johnson's share price is $163.72. Johnson & Johnson's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2021 was $8.45. Hence, Johnson & Johnson's Price-to-Free-Cash-Flow Ratio for today is 19.38.

The historical rank and industry rank for Johnson & Johnson's Price-to-Free-Cash-Flow or its related term are showing as below:

NYSE:JNJ' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.89   Med: 19.68   Max: 24.34
Current: 19.38

11.89
24.34

During the past 13 years, Johnson & Johnson's highest Price-to-Free-Cash-Flow Ratio was 24.34. The lowest was 11.89. And the median was 19.68.

NYSE:JNJ's Price-to-Free-Cash-Flow is ranked higher than
56% of the 48 Companies
in the Drug Manufacturers industry.

( Industry Median: 25.07 vs. NYSE:JNJ: 19.38 )

Johnson & Johnson's Free Cash Flow per Share for the three months ended in Jun. 2021 was $1.69. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $8.45.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Johnson & Johnson was 29.30% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 5.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 6.80% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 5.90% per year.

During the past 13 years, Johnson & Johnson's highest 3-Year average Free Cash Flow per Share Growth Rate was 45.50% per year. The lowest was -4.50% per year. And the median was 12.60% per year.


Johnson & Johnson Price-to-Free-Cash-Flow Historical Data

The historical data trend for Johnson & Johnson's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.68 21.58 19.00 19.66 20.82

Johnson & Johnson Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.53 21.72 20.82 21.04 19.50

Competitive Comparison

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Johnson & Johnson Price-to-Free-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Price-to-Free-Cash-Flow falls into.



Johnson & Johnson Price-to-Free-Cash-Flow Calculation

Johnson & Johnson's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=163.72/8.449
=19.38

Johnson & Johnson's Share Price of today is $163.72.
Johnson & Johnson's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.45.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Johnson & Johnson  (NYSE:JNJ) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Johnson & Johnson Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson Business Description

Johnson & Johnson logo
Industry
Healthcare » Drug Manufacturers NAICS : 325412 SIC : 2834
Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States.
Executives
Weinberger Mark A director METLIFE, INC. 200 PARK AVENUE NEW YORK NY 10166
Hewson Marillyn A director C/O CARPENTER TECHNOLOGY CORPORATION PO BOX 14662 READING PA 19612-4662
Washington A. Eugene director ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Wengel Kathryn E officer: EVP, Chief GSC Officer JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Mcevoy Ashley officer: EVP, WW Chair, Medical Devices JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Perez William D director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: PEREZ WILLIAM D a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Mongon Thibaut officer: Exec VP, WW Chair, Consumer JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Stoffels Paulus officer: Vice Chair, Exec Committee ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Ullmann Michael H officer: Exec VP, General Counsel JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Fasolo Peter officer: Exec VP, Chief HR Officer JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Wolk Joseph J officer: Exec VP, CFO JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Taubert Jennifer L officer: EVP, WW Chair, Pharmaceuticals JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Sneed Michael E officer: EVP, Global Corp Aff & COO JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Decker Robert J officer: Controller, CAO ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Gorsky Alex director, officer: Chairman, CEO JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933

Johnson & Johnson Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)